Egypt's acne therapeutics market is projected to grow from $28 Mn in 2022 to $53 Mn in 2030 with a CAGR of 8.2% for the year 2022-2030. Major market drivers include the growing prevalence of acne and the demand for novel therapeutics such as hormonal therapy for its treatment in Egypt. The Egypt acne therapeutics market is segmented by treatment, route of administration, age group, and by distribution channel. Copad Pharma, Delta Pharma, and Proactiv Company Sàrl are the key players in the market.
The Egypt acne therapeutics market size is at around $28 Mn in 2022 and is projected to reach $53 Mn in 2030, exhibiting a CAGR of 8.2% during the forecast period. The new budget's overall spending is anticipated to reach $89 Bn. In addition to $0.62 Bn designated for the provision of medications and medical equipment, $0.36 Bn had been set aside for health insurance and the state-funded treatment of the deprived. Despite obstacles and financial constraints, the state budget allotted $10.13 Bn for health.
Acne is a long-lasting inflammatory condition that affects the pilosebaceous unit and is defined by seborrhea, comedones, papules, pustules, nodules, cysts, and, in some cases, scars and keloids. Egypt had a 34.7% self-reported acne prevalence. Significantly more women than men (39.1% vs. 30.3%) reported having acne breakouts. In Egypt, the prevalence of clinically confirmed acne was 24.4%, with females experiencing higher rates (28.6%) than males (20.25%). Acne is frequently noticeable on the face, exacerbating issues of body image and socialization. It is therefore not surprising that someone with facial acne may experience serious psychosocial disability. Teenagers are preoccupied with idealized versions of beauty all the time.
Acne treatment in Egypt seeks to manage current lesions, avoid permanent scarring as much as possible, shorten the duration of the condition, reduce morbidity, and prevent the development of new lesions. Anti-acne medications may work by restoring normal follicle keratinization, so reducing the production of sebum. Others reduce inflammation and Cutibacterium acnes growth-promoting sebum oxidation by acting as antibacterial agents against the bacteria and decreasing C. acnes growth.
In Egypt, topical therapies alone or in combination with systemic therapies in severe cases are used to tackle acne. Comedolytic agents, antibiotics, and different anti-inflammatory medications are examples of agents used topically. Agents that are administered systemically include hormones, antibiotics, zinc, and retinoids. Herbal therapy for acne has been promoted due to the benefits of improved patient tolerance, a lengthy history of use, fewer side effects, and is less expensive.
Market Growth Drivers
The high prevalence of skin disorders, rising health awareness, and increased healthcare spending are the main factors propelling the growth of Egypt's acne therapeutics market. The market is also expanding as a result of the rising demand for hormonal therapy for the treatment of acne.
Market Restraints
It may be challenging for patients to obtain effective acne treatment in some parts of Egypt due to the lack of access to healthcare. Consequently, there may be a reduction in the need for acne therapeutics due to underdiagnosis or undertreatment of acne. The regulatory environment in Egypt can be difficult to understand and navigate, especially for pharmaceutical firms seeking to market novel acne treatments. This might reduce the number of novel acne therapeutics on the market in the nation, which might limit the Egypt acne therapeutics market expansion.
Key Players
The regulatory organization in charge of regulating the development, production, distribution, and marketing of pharmaceuticals in Egypt is called the Egyptian Drug Authority (EDA). It is an agency under the Egyptian Ministry of Health and Population, and one of its main responsibilities is to guarantee the efficacy, safety, and calibre of pharmaceutical goods sold in the nation. The EDA is in charge of overseeing the safety and effectiveness of medicines that are already on the market as well as examining and approving applications for the registration of new drugs. Furthermore, it performs manufacturing facility inspections and enforces adherence to good manufacturing practices (GMPs) and other pertinent laws. In addition to performing regulation duties, the EDA also helps to advance R&D in Egypt's pharmaceutical sector. It works to foster industry-academia collaboration in order to progress scientific understanding and foster innovation in the pharmaceutical industry. It also offers advice and support to businesses seeking to develop new drugs.
1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Treatment (Revenue, USD Billion):
By Route of Administration (Revenue, USD Billion):
By Age Group (Revenue, USD Billion):
By Distribution Channel (Revenue, USD Billion):
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses
Need more?